Charles Schwab’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-17,873
| Closed | -$88K | – | 3618 |
|
2021
Q3 | $88K | Hold |
17,873
| – | – | ﹤0.01% | 3391 |
|
2021
Q2 | $95K | Hold |
17,873
| – | – | ﹤0.01% | 3296 |
|
2021
Q1 | $86K | Hold |
17,873
| – | – | ﹤0.01% | 3391 |
|
2020
Q4 | $78K | Hold |
17,873
| – | – | ﹤0.01% | 3331 |
|
2020
Q3 | $74K | Buy |
+17,873
| New | +$74K | ﹤0.01% | 3260 |
|
2020
Q2 | – | Sell |
-47,230
| Closed | -$137K | – | 3382 |
|
2020
Q1 | $137K | Buy |
47,230
+302
| +0.6% | +$876 | ﹤0.01% | 3072 |
|
2019
Q4 | $178K | Hold |
46,928
| – | – | ﹤0.01% | 3052 |
|
2019
Q3 | $241K | Hold |
46,928
| – | – | ﹤0.01% | 3012 |
|
2019
Q2 | $291K | Buy |
46,928
+4,381
| +10% | +$27.2K | ﹤0.01% | 3022 |
|
2019
Q1 | $303K | Sell |
42,547
-7,885
| -16% | -$56.2K | ﹤0.01% | 2937 |
|
2018
Q4 | $431K | Buy |
50,432
+1,890
| +4% | +$16.2K | ﹤0.01% | 2824 |
|
2018
Q3 | $972K | Sell |
48,542
-315
| -0.6% | -$6.31K | ﹤0.01% | 2639 |
|
2018
Q2 | $1.26M | Buy |
48,857
+13,367
| +38% | +$345K | ﹤0.01% | 2507 |
|
2018
Q1 | $849K | Buy |
35,490
+4,800
| +16% | +$115K | ﹤0.01% | 2566 |
|
2017
Q4 | $1.04M | Buy |
30,690
+3,218
| +12% | +$109K | ﹤0.01% | 2494 |
|
2017
Q3 | $582K | Hold |
27,472
| – | – | ﹤0.01% | 2675 |
|
2017
Q2 | $481K | Hold |
27,472
| – | – | ﹤0.01% | 2704 |
|
2017
Q1 | $481K | Hold |
27,472
| – | – | ﹤0.01% | 2653 |
|
2016
Q4 | $465K | Hold |
27,472
| – | – | ﹤0.01% | 2681 |
|
2016
Q3 | $451K | Hold |
27,472
| – | – | ﹤0.01% | 2644 |
|
2016
Q2 | $416K | Buy |
27,472
+7,000
| +34% | +$106K | ﹤0.01% | 2654 |
|
2016
Q1 | $297K | Buy |
20,472
+6,200
| +43% | +$89.9K | ﹤0.01% | 2779 |
|
2015
Q4 | $405K | Hold |
14,272
| – | – | ﹤0.01% | 2736 |
|
2015
Q3 | $239K | Hold |
14,272
| – | – | ﹤0.01% | 2909 |
|
2015
Q2 | $375K | Buy |
+14,272
| New | +$375K | ﹤0.01% | 2788 |
|